# XOLREMDI

NDC: 83296-100
Generic name: mavorixafor
Labeler / Manufacturer: X4 Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 20240521

FDA application: NDA218709

## Active ingredients

- MAVORIXAFOR: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83296-100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83296-100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f3a5ee3-ca73-4876-85a0-ed1e108a2237